AVANT BRANDS INC (AVNT.CA) Stock Fundamental Analysis

TSX:AVNT • CA05353D2023

0.85 CAD
0 (0%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall AVNT gets a fundamental rating of 2 out of 10. We evaluated AVNT against 33 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of AVNT have multiple concerns. AVNT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • AVNT had negative earnings in the past year.
  • In the past year AVNT had a positive cash flow from operations.
  • In the past 5 years AVNT always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: AVNT reported negative operating cash flow in multiple years.
AVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFAVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of AVNT (-40.53%) is worse than 72.73% of its industry peers.
  • AVNT's Return On Equity of -74.11% is on the low side compared to the rest of the industry. AVNT is outperformed by 66.67% of its industry peers.
  • With a decent Return On Invested Capital value of 1.44%, AVNT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -40.53%
ROE -74.11%
ROIC 1.44%
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
AVNT.CA Yearly ROA, ROE, ROICAVNT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

  • AVNT has a Operating Margin of 1.99%. This is in the better half of the industry: AVNT outperforms 69.70% of its industry peers.
  • With a Gross Margin value of 30.58%, AVNT perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
  • AVNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.99%
PM (TTM) N/A
GM 30.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
AVNT.CA Yearly Profit, Operating, Gross MarginsAVNT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • AVNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • AVNT has more shares outstanding than it did 1 year ago.
  • AVNT has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AVNT is higher compared to a year ago.
AVNT.CA Yearly Shares OutstandingAVNT.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
AVNT.CA Yearly Total Debt VS Total AssetsAVNT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • AVNT has an Altman-Z score of -1.44. This is a bad value and indicates that AVNT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AVNT (-1.44) is worse than 60.61% of its industry peers.
  • The Debt to FCF ratio of AVNT is 6.46, which is on the high side as it means it would take AVNT, 6.46 years of fcf income to pay off all of its debts.
  • AVNT has a better Debt to FCF ratio (6.46) than 75.76% of its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that AVNT is not too dependend on debt financing.
  • AVNT's Debt to Equity ratio of 0.38 is in line compared to the rest of the industry. AVNT outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 6.46
Altman-Z -1.44
ROIC/WACC0.19
WACC7.56%
AVNT.CA Yearly LT Debt VS Equity VS FCFAVNT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • AVNT has a Current Ratio of 1.63. This is a normal value and indicates that AVNT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.63, AVNT perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • A Quick Ratio of 0.85 indicates that AVNT may have some problems paying its short term obligations.
  • AVNT's Quick ratio of 0.85 is on the low side compared to the rest of the industry. AVNT is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.85
AVNT.CA Yearly Current Assets VS Current LiabilitesAVNT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • AVNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.18%.
  • Looking at the last year, AVNT shows a very strong growth in Revenue. The Revenue has grown by 26.36%.
  • AVNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 72.25% yearly.
EPS 1Y (TTM)-22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.18%
Revenue 1Y (TTM)26.36%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%11.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVNT.CA Yearly Revenue VS EstimatesAVNT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • AVNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVNT.CA Price Earnings VS Forward Price EarningsAVNT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • AVNT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AVNT is cheaper than 90.91% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AVNT indicates a rather cheap valuation: AVNT is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.14
EV/EBITDA 4.57
AVNT.CA Per share dataAVNT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AVNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVANT BRANDS INC

TSX:AVNT (2/25/2026, 7:00:00 PM)

0.85

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-13
Earnings (Next)02-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.22%
Ins Owner ChangeN/A
Market Cap9.70M
Revenue(TTM)37.49M
Net Income(TTM)-20.02M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 4.14
P/OCF 3.99
P/B 0.36
P/tB 0.37
EV/EBITDA 4.57
EPS(TTM)-1.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY24.15%
OCF(TTM)0.21
OCFY25.09%
SpS3.29
BVpS2.37
TBVpS2.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.53%
ROE -74.11%
ROCE 2%
ROIC 1.44%
ROICexc 1.48%
ROICexgc 1.52%
OM 1.99%
PM (TTM) N/A
GM 30.58%
FCFM 6.25%
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 6.46
Debt/EBITDA 1.99
Cap/Depr 2.04%
Cap/Sales 0.24%
Interest Coverage 250
Cash Conversion 46.72%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.85
Altman-Z -1.44
F-Score3
WACC7.56%
ROIC/WACC0.19
Cap/Depr(3y)30.6%
Cap/Depr(5y)37.88%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.36%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%11.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y778.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y156.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.1%
OCF growth 3YN/A
OCF growth 5YN/A

AVANT BRANDS INC / AVNT.CA FAQ

Can you provide the ChartMill fundamental rating for AVANT BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to AVNT.CA.


Can you provide the valuation status for AVANT BRANDS INC?

ChartMill assigns a valuation rating of 2 / 10 to AVANT BRANDS INC (AVNT.CA). This can be considered as Overvalued.


How profitable is AVANT BRANDS INC (AVNT.CA) stock?

AVANT BRANDS INC (AVNT.CA) has a profitability rating of 2 / 10.